Andrew Jonathan Hillman is a biotech entrepreneur, healthcare investor, and strategic advisor based in Dallas, Texas. He is the principal of Hillman Ventures, a private family office founded in 1995, and his career spans three decades of building, operating, and exiting companies across FDA-regulated healthcare.
Built in Dallas
Midway Auto Supply was founded in Dallas in 1960, and trade press covered the company's fiftieth anniversary.[1][2] It is a business grown on service, relationships, and steady execution. Andrew Hillman leads Hillman Ventures from the same city, building durable companies guided by a simple standard: efficiency, innovation, integrity.
Andrew Hillman was born and raised in the Oak Cliff and South Dallas neighborhoods, where he started working at six. The work spanned Midway Auto Supply and Hampton Distributing, the family's self-service car washes and laundromats, and maintenance and yard work for Levine Realty on rental homes and apartments across Oak Cliff. He attended four high schools and finished at Highland Park High School in Dallas. The arc from a working Oak Cliff childhood to a three-decade record in regulated healthcare is self-made, and it still sets the standard he holds.
Four pillars of impact
Andrew Hillman's career rests on four connected pillars, each built on the operating discipline of the last.
Mergers and acquisitions
A documented track record of more than 89 ventures and more than 85 strategic exits across FDA-regulated healthcare.
Healthcare ecosystem
Hands-on operating leadership across acute care hospitals, ambulatory surgical centers, clinical laboratories, and pharmacies.
Consumer privacy advocacy
A named advocate for consumers in federal class actions defending the protection of personal data.
Academic and philanthropic
Published FDA biologic research paired with endowed undergraduate scholarships and grants.
An operator first
Before he was an investor, Andrew Hillman was an operator. He co-founded and led companies across surgical hospitals, ambulatory surgical centers, clinical laboratories, pharmacy, and medical devices, with a documented record of more than 89 ventures and more than 85 strategic exits. That operating experience, in regulated, capital-intensive, and clinically demanding businesses, is the foundation for everything that followed.
Past companies: Dynacq Healthcare, Inc.; Nobilis Health Corp. (formerly Northstar Healthcare); Bone Solutions.
From building companies to backing them
Today his focus is forward-looking. Through Hillman Ventures, he invests in frontier biotech and regenerative medicine for inflammation, damaged tissue, and tumor-based cancers, applying the capital discipline and regulatory judgment earned over three decades. He approaches investment the way an operator does, with attention to the science, the manufacturing, and the path to patients, not the pitch alone. His perspective on these questions is collected in his featured insights and on the venture platform. His investor role is set out in full on Andrew Hillman, Principal of Hillman Ventures.
Advisory and expertise
Andrew Hillman also advises founders, investors, and operators on FDA regulatory strategy, commercialization, and healthcare venture development through his advisory practice. He is the author of white papers spanning regenerative medicine, the FDA Section 351(a) biologics pathway, and oncology, including work on Targeted Osmotic Lysis (TOL 2.0).
Targeted Osmotic Lysis is investigational. It has not been approved by the FDA for any indication and it is not available as a treatment.
Research: Targeted Osmotic Lysis: A Novel Approach to Targeted Cancer Therapies
Giving and community
His philanthropy centers on education and community. It includes the Andrew Hillman Family Room at the Lamplighter School in Dallas, the Andrew Hillman Scholarship for Entrepreneurs, and the Andrew Hillman Grant for Biotech, alongside support for community and charitable organizations. His giving through Chabad and the Aleph Institute is an expression of his Jewish faith and his commitment to community. The full account is maintained at his community and giving site. Related: Andrew Hillman Grant for Biotech and About Andrew Hillman on the grant program site.
Family and personal life
Away from the work, Andrew Hillman keeps a disciplined routine: the gym, long walks on the Katy Trail in Dallas, and road and pedal cycling, and he lives a drug-free and alcohol-free lifestyle. A proud American, he carries the same standard that runs through his companies, efficiency, innovation, integrity, into how he lives.
A record open to verification
Andrew Hillman's background is documented in a public record he also maintains, and in established identity registries. The complete account, including public filings, recognitions, and federal records, is maintained at the public record. His verified professional identity is linked below.
Explore the work across ventures, advisory, and insights.
View the venture platformFrequently asked questions
Who is Andrew Hillman?
Andrew Jonathan Hillman is a Dallas biotech entrepreneur, healthcare investor, and strategic advisor, principal of Hillman Ventures, with three decades building and exiting FDA-regulated healthcare companies.
What does Andrew Hillman do now?
He invests in frontier biotech and regenerative medicine through Hillman Ventures, and advises on FDA regulatory strategy and commercialization.
Where is Andrew Hillman's background verified?
In a public record Andrew Hillman also maintains at andrewhillmanrecord.com, and in identity registries including Andrew Hillman, Dallas on LinkedIn, Wikidata, ORCID, and X.